drug

Baduanjin program

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by National Yang Ming Chiao Tung University
3 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

3
Exploring the Effects of a Baduanjin Program on the Symptoms of Constipation in Patients With Schizophrenia Spectrum
NCT04071444—Completed
Exploring the Effect of Baduanjin on the Metabolic Parameters and Body Mass Index of People With Schizophrenia
NCT04069988—Completed
Feasibility and Preliminary Effect of Baduanjin Program for People Diagnosed With Schizophrenia
NCT04027634—Completed

KOLs & investigators

2
Chiu-Yueh Yang, PhDKOL score 5
Li-Ru Wang, MSN

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
National Yang Ming Chiao Tung University
company
trial
Exploring the Effects of a Baduanjin Program on the Symptoms of Constipation in Patients With Schizophrenia Spectrum
NA
trial
Exploring the Effect of Baduanjin on the Metabolic Parameters and Body Mass Index of People With Schizophrenia
NA
trial
Feasibility and Preliminary Effect of Baduanjin Program for People Diagnosed With Schizophrenia
NA
trial
indication
Schizophrenia
indication
Constipation
indication
Randomized Controlled Trial
indication
Metabolic Syndrome
indication
KOL
Chiu-Yueh Yang, PhD
KOL score 5
person
Li-Ru Wang, MSN
KOL score —
person